NALBUPHINE HYDROCHLORIDE

NALBUPHINE HYDROCHLORIDE was reported 228 times

NALBUPHINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEONATAL EPILEPTIC SEIZURE 10 0.5882
1 ANTITHROMBIN III 1 0.0625
2 CARDIAC PERFUSION DEFECT 3 0.0566
3 CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0323
4 PLEURAL FISTULA 1 0.0169
5 NEONATAL ASPHYXIA 10 0.0141
6 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 1 0.0132
7 RESPIRATORY PARALYSIS 2 0.0125
8 NEUROMUSCULAR BLOCKADE 2 0.0089
9 COAGULATION FACTOR VII LEVEL DECREASED 1 0.0089
10 RENAL CELL CARCINOMA STAGE IV 1 0.0088
11 CARDIAC ARREST NEONATAL 1 0.0072
12 CONVULSIONS LOCAL 1 0.0051
13 PRODUCT CONFUSION 4 0.0050
14 DEPENDENCE ON RESPIRATOR 2 0.0050
15 CYTOTOXIC OEDEMA 1 0.0038
16 ANTITHROMBIN III DECREASED 1 0.0037
17 DIAPHRAGMATIC PARALYSIS 2 0.0033
18 ANALGESIC THERAPY 1 0.0031
19 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
20 NEONATAL RESPIRATORY DEPRESSION 1 0.0030
21 PRODUCT PACKAGE ASSOCIATED INJURY 6 0.0027
22 HYPOXIC ENCEPHALOPATHY 1 0.0024
23 URETERAL DISORDER 1 0.0024
24 GASTROINTESTINAL CANDIDIASIS 1 0.0024
25 DRUG CLEARANCE DECREASED 3 0.0023
26 CANDIDA SEPSIS 2 0.0022
27 HYPOFIBRINOGENAEMIA 2 0.0020
28 BRAIN MIDLINE SHIFT 1 0.0019
29 PERIORBITAL CELLULITIS 1 0.0019
30 MEASLES 1 0.0019
31 CYANOSIS NEONATAL 1 0.0016
32 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
33 MYCOBACTERIUM CHELONAE INFECTION 1 0.0014
34 HYPERTHERMIA MALIGNANT 2 0.0013
35 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
36 BRONCHOPULMONARY DYSPLASIA 1 0.0012
37 INFANTILE APNOEA 1 0.0012
38 BRADYCARDIA FOETAL 1 0.0012
39 MEDICATION OVERUSE HEADACHE 1 0.0012
40 CEREBRAL PALSY 1 0.0011
41 CONSCIOUSNESS FLUCTUATING 1 0.0010
42 HYPOPERFUSION 1 0.0010
43 FEBRILE BONE MARROW APLASIA 4 0.0009
44 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
45 SYSTEMIC MYCOSIS 1 0.0009
46 ACUTE PSYCHOSIS 2 0.0008
47 APGAR SCORE LOW 1 0.0008
48 BLOOD PHOSPHORUS INCREASED 2 0.0007
49 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
50 HYPOTONIA NEONATAL 1 0.0006
51 FUNGAEMIA 1 0.0006
52 SPINAL CORD DISORDER 1 0.0006
53 SPINAL DEFORMITY 1 0.0006
54 INJECTION SITE OEDEMA 1 0.0006
55 PUPIL FIXED 1 0.0006
56 SPINAL CORD INJURY 1 0.0006
57 UTERINE SPASM 1 0.0005
58 MECHANICAL VENTILATION 1 0.0005
59 CLAVICLE FRACTURE 2 0.0005
60 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
61 CONCOMITANT DISEASE PROGRESSION 1 0.0005
62 EMPYEMA 1 0.0005
63 QUADRIPLEGIA 1 0.0005
64 CAPILLARY LEAK SYNDROME 1 0.0005
65 FOETAL DISTRESS SYNDROME 1 0.0005
66 DEREALISATION 1 0.0005
67 FACIAL PALSY 1 0.0005
68 CEREBELLAR SYNDROME 1 0.0005
69 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
70 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
71 ACUTE HEPATIC FAILURE 6 0.0004
72 BRAIN OPERATION 1 0.0004
73 FORMICATION 3 0.0004
74 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
75 SYSTEMIC CANDIDA 1 0.0004
76 HYPOTHERMIA 4 0.0004
77 HAEMODYNAMIC INSTABILITY 3 0.0004
78 PERSONALITY DISORDER 1 0.0004
79 AREFLEXIA 1 0.0004
80 DRUG SCREEN FALSE POSITIVE 1 0.0004
81 ENDOTRACHEAL INTUBATION 1 0.0004
82 SCOLIOSIS 2 0.0003
83 RESPIRATORY RATE DECREASED 1 0.0003
84 PANCREATITIS ACUTE 7 0.0003
85 IMMUNE SYSTEM DISORDER 4 0.0003
86 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
87 HYPOALBUMINAEMIA 2 0.0003
88 PNEUMONIA FUNGAL 1 0.0003
89 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
90 ENCEPHALOPATHY 6 0.0002
91 ANAPHYLACTOID REACTION 1 0.0002
92 HEMIPLEGIA 2 0.0002
93 SUSPECTED OFF LABEL USE 1 0.0002
94 VASCULAR DEVICE INFECTION 1 0.0002
95 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
96 COLITIS MICROSCOPIC 1 0.0002
97 PULSE ABSENT 1 0.0002
98 VITREOUS FLOATERS 2 0.0002
99 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
100 TRISMUS 1 0.0002
101 MALABSORPTION 1 0.0002
102 BEHAVIOUR DISORDER 1 0.0002
103 NECROSIS 1 0.0002
104 ACUTE PULMONARY OEDEMA 1 0.0002
105 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
106 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
107 DRUG ABUSER 1 0.0002
108 SCREAMING 1 0.0002
109 ROTATOR CUFF SYNDROME 2 0.0002
110 HEPATITIS ACUTE 1 0.0002
111 HERPES SIMPLEX 1 0.0002
112 WALKING AID USER 1 0.0002
113 PRODUCT LABEL ISSUE 1 0.0001
114 DROOLING 1 0.0001
115 HAIR GROWTH ABNORMAL 1 0.0001
116 MENTAL STATUS CHANGES 4 0.0001
117 PAPULE 1 0.0001
118 DERMATITIS BULLOUS 1 0.0001
119 RASH PUSTULAR 1 0.0001
120 ORAL DISORDER 1 0.0001
121 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
122 HYPERTHERMIA 1 0.0001
123 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
124 POST PROCEDURAL INFECTION 1 0.0001
125 HICCUPS 1 0.0001
126 MENSTRUAL DISORDER 1 0.0001
127 PURPURA 1 0.0001
128 DEVELOPMENTAL DELAY 1 0.0001
129 EXOSTOSIS 1 0.0001
130 AGRANULOCYTOSIS 2 0.0001
131 PRODUCT PACKAGING ISSUE 1 0.0001
132 AFFECT LABILITY 1 0.0001
133 SINUS BRADYCARDIA 1 0.0001
134 BLADDER DISORDER 1 0.0001
135 BRAIN INJURY 1 0.0001
136 SUBARACHNOID HAEMORRHAGE 1 0.0001
137 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
138 BODY HEIGHT DECREASED 1 0.0001
139 DECREASED ACTIVITY 1 0.0001
140 SKIN LACERATION 1 0.0001
141 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
142 GASTROINTESTINAL PAIN 1 0.0001
143 RASH MACULO-PAPULAR 2 0.0001
144 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
145 MALNUTRITION 1 0.0001
146 SNEEZING 2 0.0001
147 ELECTROLYTE IMBALANCE 1 0.0001
148 POST PROCEDURAL HAEMORRHAGE 1 0.0001
149 CAESAREAN SECTION 1 0.0001
150 INJECTION SITE EXTRAVASATION 1 0.0001
151 BRAIN OEDEMA 1 0.0001
152 HEPATIC CYTOLYSIS 1 0.0001
153 ANAPHYLACTIC SHOCK 2 0.0001
154 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
155 UNRESPONSIVE TO STIMULI 2 0.0001
156 BLINDNESS 3 0.0001
157 TACHYPNOEA 1 0.0001
158 AKATHISIA 1 0.0001
159 BLINDNESS UNILATERAL 1 0.0001
160 BRONCHOSPASM 1 0.0001
161 HYPOKINESIA 1 0.0001
162 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
163 RESPIRATORY DISORDER 2 0.0001
164 APHASIA 2 0.0001
165 EJECTION FRACTION DECREASED 1 0.0001
166 THERAPY PARTIAL RESPONDER 1 0.0001
167 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
168 ULCER 1 0.0001
169 SENSORY DISTURBANCE 1 0.0001
170 BACK DISORDER 1 0.0001
171 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
172 VISUAL ACUITY REDUCED 2 0.0001
173 EXPIRED PRODUCT ADMINISTERED 2 0.0001
174 FACE OEDEMA 1 0.0001
175 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
176 MULTI-ORGAN FAILURE 1 0.0001
177 NEUROTOXICITY 1 0.0001
178 METASTASES TO LIVER 1 0.0001
179 BRADYCARDIA 3 0.0001
180 GOUT 1 0.0001
181 RESTLESS LEGS SYNDROME 1 0.0001
182 RESPIRATORY FAILURE 4 0.0001
183 END STAGE RENAL DISEASE 1 0.0001
184 OXYGEN SATURATION DECREASED 3 0.0001
185 HALLUCINATION 4 0.0001
186 PROTEINURIA 1 0.0001
187 CONVULSION 3 0.0001
188 LOWER LIMB FRACTURE 1 0.0001
189 HAEMORRHOIDS 1 0.0001
190 WHEEZING 3 0.0001
191 DISORIENTATION 2 0.0001
192 BLOOD PRESSURE ABNORMAL 1 0.0001
193 UPPER LIMB FRACTURE 1 0.0001
194 CYTOKINE RELEASE SYNDROME 1 0.0000
195 PRODUCT ADMINISTRATION ERROR 1 0.0000
196 FEEDING DISORDER 1 0.0000
197 BONE MARROW FAILURE 1 0.0000
198 RIB FRACTURE 1 0.0000
199 PERITONITIS 1 0.0000
200 WITHDRAWAL SYNDROME 2 0.0000
201 HALLUCINATION, VISUAL 1 0.0000
202 RETCHING 1 0.0000
203 JOINT INJURY 1 0.0000
204 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
205 TACHYCARDIA 4 0.0000
206 STEVENS-JOHNSON SYNDROME 1 0.0000
207 PRODUCT PRESCRIBING ERROR 1 0.0000
208 PRODUCTIVE COUGH 2 0.0000
209 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
210 LEUKOPENIA 2 0.0000
211 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
212 JAUNDICE 1 0.0000
213 PAIN OF SKIN 1 0.0000
214 RESPIRATORY ARREST 1 0.0000
215 INTENTIONAL PRODUCT MISUSE 3 0.0000
216 ACUTE MYOCARDIAL INFARCTION 1 0.0000
217 URINARY INCONTINENCE 1 0.0000
218 RENAL INJURY 1 0.0000
219 CORONARY ARTERY DISEASE 1 0.0000
220 EPILEPSY 1 0.0000
221 FEMUR FRACTURE 1 0.0000
222 DRUG INTERACTION 5 0.0000
223 METABOLIC ACIDOSIS 1 0.0000
224 AMNESIA 2 0.0000
225 BLOOD CREATININE INCREASED 2 0.0000
226 STAPHYLOCOCCAL INFECTION 1 0.0000
227 FUNGAL INFECTION 1 0.0000
228 URINARY RETENTION 1 0.0000
229 URTICARIA 5 0.0000
230 TYPE 2 DIABETES MELLITUS 1 0.0000
231 DELIRIUM 1 0.0000
232 RASH MACULAR 1 0.0000
233 CEREBRAL HAEMORRHAGE 1 0.0000
234 CRYING 1 0.0000
235 PRODUCT USE ISSUE 5 0.0000
236 DYSARTHRIA 1 0.0000
237 CHRONIC KIDNEY DISEASE 2 0.0000
238 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
239 ARTHRITIS 2 0.0000
240 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
241 HYPOTENSION 5 0.0000
242 SOMNOLENCE 5 0.0000
243 CONFUSIONAL STATE 4 0.0000
244 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
245 OSTEOPOROSIS 1 0.0000
246 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
247 CARDIO-RESPIRATORY ARREST 1 0.0000
248 RENAL IMPAIRMENT 2 0.0000
249 HYPERTENSION 5 0.0000
250 RENAL FAILURE ACUTE 1 0.0000
251 LOSS OF CONSCIOUSNESS 3 0.0000
252 SEPTIC SHOCK 1 0.0000
253 LIVER DISORDER 1 0.0000
254 PULMONARY OEDEMA 1 0.0000
255 THERAPY NON-RESPONDER 1 0.0000
256 HYPERSENSITIVITY 4 0.0000
257 RENAL DISORDER 1 0.0000
258 COGNITIVE DISORDER 1 0.0000
259 COMA 1 0.0000
260 RENAL CANCER 1 0.0000
261 MIGRAINE 2 0.0000
262 CONTUSION 2 0.0000
263 HYPOGLYCAEMIA 1 0.0000
264 LUNG DISORDER 1 0.0000
265 BLOOD PRESSURE INCREASED 3 0.0000
266 ACUTE KIDNEY INJURY 3 0.0000
267 HAEMOGLOBIN DECREASED 2 0.0000
268 ILLNESS 2 0.0000
269 NERVOUSNESS 1 0.0000
270 SPEECH DISORDER 1 0.0000
271 PANCREATITIS 1 0.0000
272 OFF LABEL USE 16 0.0000
273 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
274 ANAPHYLACTIC REACTION 1 0.0000
275 TREMOR 3 0.0000
276 PANCYTOPENIA 1 0.0000
277 THROMBOCYTOPENIA 2 0.0000
278 BLISTER 1 0.0000
279 HYPONATRAEMIA 1 0.0000
280 EYE PAIN 1 0.0000
281 LETHARGY 1 0.0000
282 PYREXIA 6 0.0000
283 BONE PAIN 1 0.0000
284 FEELING ABNORMAL 4 0.0000
285 VERTIGO 1 0.0000
286 MALAISE 7 0.0000
287 PRURITUS 6 0.0000
288 DEEP VEIN THROMBOSIS 1 0.0000
289 FEBRILE NEUTROPENIA 1 0.0000
290 BLOOD PRESSURE DECREASED 1 0.0000
291 NEOPLASM MALIGNANT 1 0.0000
292 VOMITING 7 0.0000
293 ERYTHEMA 3 0.0000
294 VISION BLURRED 2 0.0000
295 COUGH 4 0.0000
296 BURNING SENSATION 1 0.0000
297 INJURY 1 0.0000
298 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
299 ANXIETY 4 0.0000
300 OVERDOSE 3 0.0000
301 ACNE 1 0.0000
302 CONDITION AGGRAVATED 4 0.0000
303 DIABETES MELLITUS 1 0.0000
304 CARDIAC FAILURE 1 0.0000
305 DRUG DEPENDENCE 2 0.0000
306 DRY MOUTH 1 0.0000
307 CARDIAC ARREST 1 0.0000
308 TOXICITY TO VARIOUS AGENTS 2 0.0000
309 CEREBROVASCULAR ACCIDENT 2 0.0000
310 PRODUCT STORAGE ERROR 1 0.0000
311 PAIN 7 0.0000
312 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
313 NO ADVERSE EVENT 2 0.0000
314 SWELLING 1 0.0000
315 DYSPHAGIA 1 0.0000
316 ANAEMIA 2 0.0000
317 FLUSHING 1 0.0000
318 RASH 4 0.0000
319 CONSTIPATION 2 0.0000
320 DRUG INEFFECTIVE 12 0.0000
321 FALL 3 0.0000
322 SEPSIS 1 0.0000
323 SEIZURE 1 0.0000
324 VISUAL IMPAIRMENT 1 0.0000
325 ASTHENIA 3 0.0000
326 HEADACHE 5 0.0000
327 HYPERHIDROSIS 1 0.0000
328 RENAL FAILURE 1 0.0000
329 PRODUCT QUALITY ISSUE 1 0.0000
330 NEUTROPENIA 1 0.0000
331 MEMORY IMPAIRMENT 1 0.0000
332 WEIGHT DECREASED 2 0.0000
333 HYPOAESTHESIA 1 0.0000
334 FATIGUE 5 0.0000
335 PARAESTHESIA 1 0.0000
336 NAUSEA 5 0.0000
337 PNEUMONIA 2 0.0000
338 ABDOMINAL DISCOMFORT 1 0.0000
339 MYOCARDIAL INFARCTION 1 0.0000
340 MUSCLE SPASMS 1 0.0000
341 NASOPHARYNGITIS 1 0.0000
342 GAIT DISTURBANCE 1 0.0000
343 ABDOMINAL PAIN UPPER 1 0.0000
344 DEPRESSION 1 0.0000
345 DECREASED APPETITE 1 0.0000
346 BACK PAIN 1 0.0000
347 ABDOMINAL PAIN 1 0.0000
348 DIZZINESS 2 0.0000
349 INSOMNIA 1 0.0000
350 DYSPNOEA 2 0.0000
351 PAIN IN EXTREMITY 1 0.0000
352 ARTHRALGIA 1 0.0000
353 DEATH 1 0.0000